hotspot -WSS

hotspot

author：focus 2025-08-12 09:13:04 - browse：27977

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Some dementia cases could be undiagnosed liver disease

WSS

Rise in cancer among younger people worries and puzzles doctors

Vertex non

Former reverend arrested for allegedly killing 8

SAMSHA loosens regulations on methadone treatment centers

General Catalyst, Summa Health deal will turn on physician buy

'Investigate these claims': UFO transparency at center of House hearing

explore

hotspot

focus

After affirmative action ruling, medical educators look to 'holistic review'

Rise in cancer among younger people worries and puzzles doctors

Medical records are filled with copy

Juul spent big to court Black leaders to promote its e

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Alkermes shareholders re

Vertex non

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

hotspot

What it's like to live with paralysis for one psychologist

Quicker fix for pulse oximeters urged during FDA public meeting

Cognito secures funding to test medical device for Alzheimer's

The battle over 'scope creep' and who gets to be called 'doctor'

UHS says company favors patients whose insurance pays more

What we need to know about Arena Bioworks

knowledge

explore

hotspot

leisure time